08 Aug 2022 --- The US Food and Drug Administration (FDA) announces that additional supplies of specialty formula are incoming from The Netherlands-based Nestlé Health Science. The shipment will include hypoallergenic formula as well as formula for infants with cow’s milk protein allergy (CMPA).
